Table 7.
Values for energy from docking estimates of complexes (1–3) with Crystalline phase of COVID-19 (SARS-CoV-2) (6XBH) and breast cancer mutant (3hb5).
| Compound | Protein | S (kcal/mol) | moiety | Receptor site | Interaction | Distance (Aο) | E (kcal/mol) |
|---|---|---|---|---|---|---|---|
| (1) | 6XBH | −5.9263 | N44 | SD MET 49 | H-donor | 3.69 | −1.0 |
| O47 | O GLU 166 | H-donor | 2.70 | −2.0 | |||
| N8 | 5-ring HIS 41 | H-Pi | 4.34 | −1.3 | |||
| 6-ring | CA PRO 168 | Pi-H | 4.01 | −0.7 | |||
| (1) | 3hb5 | −8.5654 | N 7 | OG1 THR 190 | H-acceptor | 3.19 | −1.3 |
| O 53 | N LEU 95 | H-acceptor | 3.34 | −0.7 | |||
| 6-ring | CA GLY 13 | Pi-H | 4.48 | −1.2 | |||
| (2) | 6XBH | −7.1820 | N44 | SD MET 49 | H-donor | 3.32 | 0.2 |
| O47 | OD1 ASN 142 | H-donor | 2.69 | −3.8 | |||
| O 60 | NE2 HIS 163 | H-acceptor | 3.09 | −5.1 | |||
| (2) | 3hb5 | −8.0702 | O 49 | O GLY 186 | H-donor | 3.14 | −1.4 |
| N 44 | CA SER 222 | H-acceptor | 3.42 | −0.7 | |||
| O 47 | N VAL 188 | H-acceptor | 3.52 | −1.1 | |||
| 6-ring | CG1 VAL 225 | Pi-H | 4.67 | −0.6 | |||
| (3) | 6XBH | −7.0347 | O 47 | OE1 GLU 166 | H-donor | 2.71 | −5.8 |
| O 48 | OE2 GLU 166 | H-donor | 2.57 | −4.9 | |||
| 6-ring | N GLU 166 | Pi-H | 4.51 | −0.6 | |||
| (3) | 3hb5 | −7.0581 | Cl 46 | CB SER 142 | H-acceptor | 3.34 | −1.1 |
| Cl 46 | CB CYS 185 | H-acceptor | 3.57 | −0.9 |